comparemela.com
Home
Live Updates
Breakthrough Cooperation of Legend Capitals Cross-border Portfolio Companies: Innovent and Etana Jointly Announce the Approval of Bevagen by the BPOM : comparemela.com
Breakthrough Cooperation of Legend Capital's Cross-border Portfolio Companies: Innovent and Etana Jointly Announce the Approval of Bevagen by the BPOM
HONG KONG, June 15, 2022 - (ACN Newswire) - On June 14, two of Legend Capital's portfolio companies, Innovent Biologics, Inc. ("Innovent") and PT Etana Biotechnologies Indonesia ("Etana"), jointly announced
Related Keywords
China
,
Indonesia
,
Indonesian
,
Chinese
,
Innovent Biologics
,
Frank Hong
,
Nathan Tirtana
,
Fei Qi
,
Exegenesis Bio
,
Michael Yu
,
Innostellar Biotherapeutics
,
Recbio Technology
,
Kawin Technology
,
Drugs Authority
,
Lynk Pharmaceuticals
,
Innovent Biologics Inc
,
Business Development
,
Legend Capital
,
Biotechnologies Indonesia
,
Indonesian Food
,
President Director
,
Southeast Asian
,
Managing Director
,
Executive Director
,
Southeast Asia
,
Glubio Pharmaceutical
,
Ribo Life Science
,
Breakthrough
,
Cooperation
,
Legend
,
Capital
,
Cross
,
Order
,
Portfolio
,
Companies
,
Innovent
,
Astana
,
Ointly
,
Nnounce
,
Approval
,
Prevagen
,
Pom
,
comparemela.com © 2020. All Rights Reserved.